IRIS Accounts Production v24.3.2.46 03220795 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032207952023-08-31032207952024-08-31032207952023-09-012024-08-31032207952022-08-31032207952022-09-012023-08-31032207952023-08-3103220795ns15:EnglandWales2023-09-012024-08-3103220795ns14:PoundSterling2023-09-012024-08-3103220795ns10:Director12023-09-012024-08-3103220795ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3103220795ns10:SmallEntities2023-09-012024-08-3103220795ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3103220795ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3103220795ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3103220795ns10:FullAccounts2023-09-012024-08-310322079512023-09-012024-08-3103220795ns10:Director22023-09-012024-08-3103220795ns10:CompanySecretary12023-09-012024-08-3103220795ns10:RegisteredOffice2023-09-012024-08-3103220795ns5:CurrentFinancialInstruments2024-08-3103220795ns5:CurrentFinancialInstruments2023-08-3103220795ns5:ShareCapital2024-08-3103220795ns5:ShareCapital2023-08-3103220795ns5:RetainedEarningsAccumulatedLosses2024-08-3103220795ns5:RetainedEarningsAccumulatedLosses2023-08-3103220795ns5:NetGoodwill2023-09-012024-08-3103220795ns5:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3103220795ns5:LandBuildingsns5:ShortLeaseholdAssets2023-09-012024-08-3103220795ns5:FurnitureFittings2023-09-012024-08-3103220795ns5:MotorVehicles2023-09-012024-08-3103220795ns5:ComputerEquipment2023-09-012024-08-3103220795ns5:NetGoodwill2023-08-3103220795ns5:NetGoodwill2024-08-3103220795ns5:NetGoodwill2023-08-3103220795ns5:LandBuildingsns5:ShortLeaseholdAssets2023-08-3103220795ns5:LeaseholdImprovements2023-08-3103220795ns5:PlantMachinery2023-08-3103220795ns5:LeaseholdImprovements2023-09-012024-08-3103220795ns5:PlantMachinery2023-09-012024-08-3103220795ns5:LandBuildingsns5:ShortLeaseholdAssets2024-08-3103220795ns5:LeaseholdImprovements2024-08-3103220795ns5:PlantMachinery2024-08-3103220795ns5:LandBuildingsns5:ShortLeaseholdAssets2023-08-3103220795ns5:LeaseholdImprovements2023-08-3103220795ns5:PlantMachinery2023-08-3103220795ns5:FurnitureFittings2023-08-3103220795ns5:MotorVehicles2023-08-3103220795ns5:ComputerEquipment2023-08-3103220795ns5:FurnitureFittings2024-08-3103220795ns5:MotorVehicles2024-08-3103220795ns5:ComputerEquipment2024-08-3103220795ns5:FurnitureFittings2023-08-3103220795ns5:MotorVehicles2023-08-3103220795ns5:ComputerEquipment2023-08-3103220795ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3103220795ns5:WithinOneYearns5:CurrentFinancialInstruments2023-08-31
REGISTERED NUMBER: 03220795 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2024

FOR

WALKERS PHARMACY LIMITED

WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WALKERS PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2024







DIRECTORS: T Kaur
M Singh





SECRETARY: M Singh





REGISTERED OFFICE: Corner Oak
1 Homer Road
Solihull
B91 3QG





REGISTERED NUMBER: 03220795 (England and Wales)





ACCOUNTANTS: Prime
Chartered Accountants
Corner Oak
1 Homer Road
Solihull
B91 3QG

WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

BALANCE SHEET
31 AUGUST 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 416,525 490,029
Tangible assets 5 399,184 450,131
815,709 940,160

CURRENT ASSETS
Stocks 165,000 176,000
Debtors 6 614,768 392,957
Cash at bank and in hand 2,411,640 2,315,885
3,191,408 2,884,842
CREDITORS
Amounts falling due within one year 7 673,520 741,608
NET CURRENT ASSETS 2,517,888 2,143,234
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,333,597

3,083,394

PROVISIONS FOR LIABILITIES 27,696 36,013
NET ASSETS 3,305,901 3,047,381

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 3,305,801 3,047,281
3,305,901 3,047,381

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

BALANCE SHEET - continued
31 AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2025 and were signed on its behalf by:





M Singh - Director


WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024


1. STATUTORY INFORMATION

Walkers Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Goodwill, being the amount paid in connection with the acquisition of a business in 2020, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - 4% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33.33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 28 (2023 - 28 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 September 2023
and 31 August 2024 1,335,044
AMORTISATION
At 1 September 2023 845,015
Amortisation for year 73,504
At 31 August 2024 918,519
NET BOOK VALUE
At 31 August 2024 416,525
At 31 August 2023 490,029

WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


5. TANGIBLE FIXED ASSETS
Improvements
Short to Plant and
leasehold property machinery
£    £    £   
COST
At 1 September 2023
and 31 August 2024 420,127 8,737 172,998
DEPRECIATION
At 1 September 2023 121,839 946 67,030
Charge for year 16,805 874 26,492
At 31 August 2024 138,644 1,820 93,522
NET BOOK VALUE
At 31 August 2024 281,483 6,917 79,476
At 31 August 2023 298,288 7,791 105,968

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 September 2023
and 31 August 2024 181,194 18,617 2,876 804,549
DEPRECIATION
At 1 September 2023 151,016 12,235 1,352 354,418
Charge for year 4,527 1,596 653 50,947
At 31 August 2024 155,543 13,831 2,005 405,365
NET BOOK VALUE
At 31 August 2024 25,651 4,786 871 399,184
At 31 August 2023 30,178 6,382 1,524 450,131

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 368,323 327,409
Other debtors 246,445 65,548
614,768 392,957

WALKERS PHARMACY LIMITED (REGISTERED NUMBER: 03220795)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 414,478 414,567
Taxation and social security 151,409 178,763
Other creditors 107,633 148,278
673,520 741,608